Following pioneering campaigns from families of patients and doctors, there has been a significant change to UK legislation in regards to cannabis, which have now made it legal to produce and prescribe products derived from the drug. This has opened up a significant new marketplace for cannabis in the UK, one which pharmaceutical businesses and the limited number of companies licensed to cultivate the drug for medical use in Britain, are looking to exploit.
But as with any industry, they need the support of an experienced legal team as they face a quickly evolving, complex set of regulatory and commercial challenges.
Mackrell Turner Garrett is at the heart of this revolutionary change and is able to provide advice and support to the growing number of companies looking to enter this sector.
The depth of its knowledge that it has access to in this industry is without comparison, thanks to its ability to call on the knowledge and experience of other legal professionals in places like the United States and Canada, where cannabis has been legalised, through its position as a founding member of the Mackrell International global legal network.
As with any emerging market, investors and businesses prioritise credibility and connectivity above value, which is why our pool of global expertise puts Mackrell Turner Garret ahead of the curve as the commercial market evolves in the UK.
With attitudes to cannabis changing around the world, the future may hold many more opportunities for UK businesses.